advisorsecurities master

VBIOValion Bio, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
23237
Ticker
VBIO
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-11-11
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
VBIO

Detail

Enriched 2026-08-14 20:47

Market cap
$938,184.53
Shares outstanding (class)
4,151,259
Shares outstanding (weighted)
4,151,259
SIC
3845 ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Employees
52
Location
SAN ANTONIO, TX
Description

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data